Nobel Prize in chemistry awarded to two women who developed CRISPR, a revolutionary gene-editing tool
By Ben Guarino,
Washington Post
| 10. 07. 2020
A pair of scientists — Jennifer A. Doudna, a biochemist at the University of California at Berkeley, and Emmanuelle Charpentier, a French microbiologist — won the 2020 Nobel Prize in chemistry Wednesday for their work developing a revolutionary gene-editing tool that can change the DNA of plants and animals with extraordinary precision. The technique, called CRISPR -Cas9, is already being used as a cancer therapy and to cure inherited diseases.
“This year’s prize is about rewriting the code of life,” said Goran K. Hansson, secretary general of the Royal Swedish Academy of Sciences.
This was the first time two women jointly won a Nobel in chemistry. “I wish that this will provide a positive message, specifically, to young girls who would like to follow the path of science,” Charpentier told reporters Wednesday morning.
“I’m over the moon, I’m in shock, I couldn’t be happier,” Doudna said at a University of California at Berkeley news conference. She said she and Charpentier are “waving to each other across the Atlantic right now.”
Francis Collins, director of the National Institutes of Health, said...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...